Tobacco Documents Online

othec•aire"  An interview with James R. Kimmey, M.D., M.P.H., leaves little doubt that a ntajur ne,,c voice is f;uing to be hearcl, and a majcrr nevr force felt, in the debates and acticm, that ~hape the future of health care in the United titate,. The voice and the force are those of the American Public Nealth As- sc>ciati,m, c,f which I)r. Iiinmley ha~ just been namecl executive director. In existence since 1873, APHA is hardly new as an organization. But it is nr,w unelerg,,in}; a nletanlt,rl>hc,sis-a change in goals, policies, and ac- ti.-ities-scr extensive that the associatiun which emerf;es from the pr(>cess will qualify as "ne\\-" in every sense but nanle. In the making behind the scenes for se.-eral years, the change came to light at last November's annual meeting of APHA. Reports at that time. in both the meclical and lac 1>ress, spoke of a decision by the 97-year-old organization to become a chanll>inn of the consu»ler of inedical care ... ancl to challenge the American Meclical Association for health field leacl- ershil,, on the ground that AMA does not adequately serve the health neecls of the public. The change in AYHA became official in March \N•hen a new constitution Nvent into effect. hi;;ht off, Article lI of the constitutirnn-"Ubject"- sets the stage for the association's new role. The original Article II de- clared siml,l) that "the object uf tlv, asse,ciation ib to protect and prc,- mote public and 1>ersc,nal hea)th." The ne%t• clr,eunlent announces that AYHA exist> "tr, protect anci lrrul7lrne lrersrmi,il «ncl environmental health. It shall exercise leacler.shil, \vith health 1>rc,fe',sirmals and the general pub- lic in health policy development and actirm, with particular fucus on the interrelatinn~.hil) between health and the quality of life, and on develop- ing a national policy for health care ancl serrice, and on solving technical prublem~,". Action Board: Another key provision of the new constitution is the one that establi,hes an "Action Board", whose function "shall be to formulate, plan, organize and pursue the iml>lementatiun of association policies and positicros, including develolmient and l,ursuit of an annual legislative pro- graal>.,." ( Two mcmths later, in lune, the Action Board went into action-on a front directly involving the drug field. APH A brought suit in federal court to force the Food & Drug Administration to release the findings of all the efficacv, studies conducted by the National Academy of Sciences National Research Council, an(1 to renun•e from the market inlmediate)y all those products held ineffective. Although the studies involved about 4,000 products, and were completed two years ago, FDA had thus far acted on only about 2; ;i' , the suit claimed. ) Enter Dr. Kimmey, appointed executive director on August 1, charged with makinf; the nev~- AYHA a reality. An interviewer comes away with the strong impressic>n that-del>ending on how 1>harmac.•, the phanna- ceutical industrv, medicine, government, and others involved in medical care regar(l the new course the American Public Health Association has chosen for itself-thev will find )ames R. I:inmiey a formidable allY or a fonnidable foe. At 35, he is the youngest person ever to hold the executive directorship of any national health or medical organization. He is articulate, aggres- sive-and con.•inced that the "health establishment" in the l-. S. has made a mess of the distribution of health care. Is APHA1 determined ^t(> 1 take 4aealth field leadership 11aM•ay f'rr10i the A;N1A? "That's too sensational a way c>f Wontii>(rcd on Ya.fir 41 ) COOL-VAPOR HUMIDIFIER •"Air ramp" design provides maximum delivery of ultra-fine mist. • 1r/rgal. cap. runs up to 20 hrs. on one filling. • Sturdy, high-impact plastic base. Model 265 Suggested Retail $15.95 Dir. cost (std. pkg. of 6) $47.85 Reg. d,r. cost (less than 5) $9.57 . ' Speciai ' : ~ I ~ree with :p ~ othec•aire ~ . , ; Cool-Vapor Humidifiers and Steam Vaporizers Take on - and beat - any competition with these popular Apothec-a'ire units. They guar- antee you and your customers dependable Hankscraft quality - PLUS competitive prices that give you a full 0% profit! : AVAILABLE ONLY THROUGH : .• . . : : YUUR W}4DLES,ALER. HANKSCRAFT COMPANY Reedsburg, Wisconsin 53955 ApothPc -aire' STEAM VAPORIZER • Low silhouette design increases stability. • 1-gal, cap. runs 8.10 hrs. on one filling. ~ • Dependable heating element with twist-on top. Model 260 Suggested Retail $10.95 Dir. cost (std. pkg. of 6) $32.85 I ~eg, dir. coIst, (less than 5) $6.57 Also Stock Apothec=aire Vapori2er Fluid and Cleaner Tablets for Added Sales •.•-'-.., -,ecreT . e-.,,...,1,.. 7 1970 Inrprprefrng tht Ne-s • 15

r WINDOW SIGNS announcing cut prices on prescription drugs could become com• monplace, if the United States Department of Justice had its way. See story. Justice Dept. Wants II Restraints 6n Rx Ads I 16 • Interpreling the News AO ERICAN DRUIbG'~T • $epiemblelr 7I 797C

AMERICAN DRUGGIST THE A\TITIa-ST DIVISION of the t-. S. Dept of ]ustice believe,, that state laws and regula- tions w•hich restrict prescription drug advertising should be repealed. It has called on the Council of State Governments to take steps in this direction. Composed of representatives of all states, the Council publishes an annual listing of "Suggested titate Legislation", which has considerable inflnence in state capitol~,. Roland W. llonnem, director of policy planning of the justice Dept Antitrust Dirision, also singled out prescription ad restrictions as special targets for action in recent addresses before the American Bar Assn and the Assn of State Attorneys (Jeneral. 'Artificially high': According to Mr. Donnem, about 29 states, "either bv statute or regulation, generally prevent the advertising of prescription Eliminated f drug by name or price, and about 10 prohibit the use of ternTs such as 'discount', 'cut-rate', and so forth in the advertising of prescription drugs." NIr. Donnem claimed that "the principal effect of restricting drug advertising is sharp curtailment of price competition, with resulting stabilization of retail drug prices at artificially high levels. In view of the alarming rate of recent increases in generil health costs, which fall especially hard upon the elderly and the poor, it seems that sound economic artld social ,poliqv dictate I,tllat, am. il competitive re- straints which have the effect of raising drug co,: should be kept to the minimum required by consi,l- erations of public safety. "Thus, w•e suggest that the states, which bear a portion of the burcten of high drug prices under the \Iedicaid program, re-examine the essential premise upon which the advertising restrictions are based : that is, that the advertising of pres:~rip- tion drugs will endanger the public health \'t e are inclined to believe that the premise is largely er- roneous. Other restraints: :\Ir. Donnem also wants the states to take action against what he described as "other market restraints affecting the retail drug industry". He cited "such things as the laws and regulations which limit drug store ownership to pharmacists, require that establishments sellinz drugs at retail be managed by pharmacists, regtt- late the number of pharmacists which must be em- plwryed. car eslxabii~lT tllzt ptllarmacists. maist be ol- duty during a store's open htnus-ever,i if the plTar- macy section is closed. "In addition to the requirements affecting own- ership, management and employment, some state laws and regulations directly affect operations in other ways. For example, there are state provisitmz~ which require the physical separation of the retai'' drug department from the non-drug area of a more general merchandise store, mandatory separate en- trances to drug and non-drug areas, prohibitions on self-service as to non-prescription drup, pro- hibitions on membership or 'closed-door' opera- tions, and control over the content of extcrnal identifying signs." In Nlr. llonnenl's view, "w•hile investigation may show specific law•,, or regulations to be justified by health or safety considerations, ts, the restraint~, mentioned here seem to nnclulv interfere w•ith coni- petition," i AMERICAN DRUGGIST • September 7, 1970 Inlerprebnc thP Ne- • 17

Does Mass. law allow substitution? New measure requires physicians to include generic names on Rxs for all drugs listed' in special state formulary A bill -which apparently will al- lclw :tlassachusett~.' hharnlacist~, tu dispense whatever drug brands the\ wish, on n1o1st llrescripti(lns, has been signed into , law by (;ov. l=rrtti- cis tiargent, t n(ler the law, a5 memlaer cnnl- ntissi,m will compile and nlaintain a list of all drurs ccminlo~n1\ 11re- scribe(1 in the state for which thera- peuti: equivalence is recognized in bc,th brand nanle and ,;eneric ver- S1c~11~. Required: Nltis;achusett~- cloctor,, wili then be required to include generic nanle_ un all hxs for clrui;,, appearing in the formulary. The\- will be permitted to sJleci7Na brand name as well-but pharmacists pre- sumalll\ wili ha-,e the (rl)tinn tu (li,- 1lense an-,- versiun, of the (Iruc~ that ther have on hand. "Yresunlal,ly", 1>ecause there is snllle (luestiom as to whether the ne«• 1ueasure in fact sanctioms unlimitecl sttbstitntinn. Rel1. l. E(lwarrl tierlin, l>rincillal sllon~,or of the ne.\• law, contends that it does. He sars it overrides ~la~~tlchll~etL• e\15t111~ a11t1-substl- A NEW substance, possibly a hor• mone, has been discovered by Dr. V. M. Buckalew Jr of Emory U, which appears to act on the kidney to cause an increase in salt excretion from the kidneys. Here, he is using a device to deter- mine if the sub- stance inhibits salt transport across a toad bladder. The research is sup- ported by a grant from the, Natiortal Insti'tu'tes"of tntl()Il ,tatute. This view i.,, shareri by Carl Rubert-,. head of the .aluer- can Pharmaceutical Assn's legal clepartment Benchmark: Althuugh ANh.-\ clichl't have anything to do with lla.,sage of the Serlin measure, the organization regards its passage as a significant step in its campaign to relleal anti-stlb5titutiun laws throughout the country. The \] assachttsetts Yharnlaceuti- cal Assn remaina uncertain abuut ex,utl\ how the Serlin bill affects llharnlacists. Assuciatinn secretarv, Lonlis 1'erlrtttt puint., uttt that the llharmacist NN•hu is handed a 1>re- scrilttiK:i11 citing 63th a 1>,rali(1 aitrl generic nanle is faced with a cli- letT finla. Liability: "lf the (luctur goes to the trouble of citing a specific brand. llresunlably that's the drug lie want~, (lispen.se(l. Even if the llharmacist is legally authorized to ~ substitute another product. we think that if lte (lc1es so, lte may be placing him- self in real je(lllar(ly if, for am• reason, the generic item fails to per- f,)r111 in a way that satisfies the pre- scriber. \\'e tliiuk that under sucl, circttmstance~,. the l,harnl<<ci~t' biliv,m-iv be tremenrlnn~.." l~n(ler the Serlin llill, the fornlu- lary ccmmii~-:~irllt l which will 11rol,- al)l% include rnle ptlarnlaci,t menl- ber I will make it~, asse.~sment of theralletttic ecluivalency n1l the of existing material. inchl(linl; ]lita) i(irnlularie:, tl~ecl in :11ri~,,achu- aetts and elsewhere. ln Mr. Yermut', view, thi~, i,~n't 11(mll enough. "The Funrl & ] )ru;g .Mministrati{ln isn't allle to attest to the tTeneric equivalency of all ltlulti111e-sclurce clrttg,. 1•-Ic1w can thi~, c(,mmi~,si<m, which (loesn't have any scieltific re~ ~urc~~, be expected toy (l(1 ,u' And huv- can irt(lividual l,lharltlacists pu„ihly (1o S_` .\lr. Permut said he had at- tempted to have the Serlin bill amencle(1 so a~, to shecifi that fc r- nlulary itent,, must be certified a~, generically ecluivalent 11y the FI)A. This effort wa,~ tutsttcressfui, he said. Education: Rep. '~',erlin told A\iER1C'Aa ]]Rt'(-,(;1RT that Stu lt after his bill is inll>lementeci, he ex- Iora't, l~lt arai~.ar~; tj,atrotti! to ct;a-t a,l.",~ inr phttrm.acist!, to (lisltelase gener- ic., "My bill had the backing of clr- ;1anizecl labor in 1lassachusetts, a~, well as senior citizens and other co~nsnnier gro1n11~,." lie saicl. "I think these urhanizatiuns will go to sc,mr lengths to e(hlcatc their nlenlher~- ahuut the benefit,, of my bill. :\s a result, Nlassachusetts 11}larltl•lcist~, will be compelled to 1 stock a lrn):ul line of generics for cun111etitiNt.1 re•is~ ms. The AYhA believcs th,tt, in a short time, the recluirenlents of th(, tierlin bill will prompt Ma,.achu- setts (lucturs to st~(rt writill', Tcneric llrescrilltioms alrllost exclusively. 'I-h(• Serlin bill exclndes patented (lrug~-, for which, as a rule, i;e•neric ~ N'r,i~ 1n; art•i Ithla;i~ttiiltlullc. pil I 18 • Inferpreiinp Ihe News AMERICAN DRUGGIST • Seplembe• 7. 1G?0

Consider all the nice things you can get with S&H Green Stamps. We'll give you 1200 free stamps- that's a full book-if you also promise to consider all the nice things a stamp program can do for your business. I accept your "bribe." Send me 1200 free S&H Green ! r ~ t Stamps-along with an S&H Representative to tell me how a trading stamp program can help my business. ~ Name ' Firm Name ' ' ' Business ' Address ' ~ City State ' Zip ! ' , Phone Area Code ' ' ' Mail to: The Sperry and Hutchinson Company, Dept. AD•35 ~ 330 Madison Avenue, New York, New York 10017 ~ AMERICAN DRUGGIST • September 7, 1970 ~ Inrerprerog ncc New, • 19

Ratio of drugs to total health spending drops Per capita amount was $30.58, or 12% of total, in 1969, vs. 14% in 1966, U.S. finds The typical American spent a total of S30.5i; on "drug, and drug sundrie." in 19t,9-11.9'- of his total ekpenl for all types of health care services. «,hich anlountecl to S2;(,.0-1. Bacl, in l9f><t, drug spending amounted to S_'5.3?, or 13.8~'~ of total health care exl>enditures of $1 83.12. These figures have just been re- ported by the Social Security Ad- ministration. rm the basis of a spe- TO KEEP FALSE EYELASHES properly shaped, dust-free, and on view for in- stant selection is the object of this new dressing table accessory, offered by Tacron Products, Freeport, N.Y. The transparent blue container is made of Bakelite polystyrene. In addition to holding 8 upper and lower lashes, it also stores applicators and adhesive. i y,i , 1 1 20 • Interpreting the Ne.v; cial study conducted by Barbara S. Cooper, of the Division of Health Insurance Studies of the SSA's Of- fice uf Research & Statistics. Another way to grasp the signifi- cance of the data is this : 19l per capita expenditure of $30.58 for drugs and drug sundries represents a 20.8% increase over the 1969 fig- ure. Un the other hancl, the S25(t.04 total for all health care spending last year represents a 39.9% increase- almost double that for drug,. "llrugs and drug sundries" is the gl ernnvent's language for the cate- gory of products that consist,, largely of inedicatiotls-prescril,- tion and non-prescription. dries" refers to first aid itenls, ther- monleters, ancl a few other sick room supplies. In dollars, ph\•sician's services accounted for most of the per-capita increase from 1900 to 1909. But in percentage of total, hospitals and nursing homes were the only cate- gories that showed increases. The follorl table gives tlle picture. For botll N ears, it shows per-capita dollar outlavs, by categorie-, ... and the percentage of total represented by each category : 196f oo+ To'o~ 19!•9 ~ioo! TotaN Hospital care .. 71.22 38,9 109.75 42.9 Physician services 44.60 24.4 58.04 22.7 Other prof. services ..... 20.15 11.0 24.92 9.7 Drugs ........ 25.32 13.8 30.58 11.9 Nursing home care ....... 7.08 3.9 11,75 4.6 Other health services ..... 14.75 8.0 21.01 8.2 Total ...... 183.12 100.0 256.04 100.0 By age: A srmlewhat different picture emerges when the figures are broken down into two age groups-those under GS, and those 65 and over. All per-capita figures are higher for the ().;-plus group. For exanTl,le, the average oldster spent $i9.-18 last year on drugs, compared with only $2' 5.45 for the typical person under 6; . How the dollar amounts and per- centages of total vary for the two age groups is shown in the following tabulatir,ns : Under 65 19h• Hospital care ... 59,90 Physician services 41.92 Other prof. services ... . . 20.02 Drugs ......... 21.51 Two 37.8 26.4 12.6 13.6 D914 86.09 52.91 24.64 25.45 40.9 25.2 11.7 12.1 Nursing home core ....... 1.12 Other health services ..... 14.03 0.7 8.9 1.30 19.91 0.6 9.5 Tota 1...... 158.49 100.0 210.30 100. 0 65 And Over I 9r: TWO `9^_ -_ - Hospital care .. 181.54 42.9 335.28 48 4 Physician services 70.73 16.7 106.99 15.5 Other prof. services ..... 21.40 5.1 27.61 4.0 Drugs ..... ,.. . 62.41 14.8 79.48 11.5 Nursing home care ....... 65.05 15.4 111.40 16.1 Other health services ..... 21.83 5.7 31.46 4.5 Total ...... 422.96 100.0 692.22 100.0 Private vs. public: All the firttr e- thus far reported refer both to money sl,ent from the inrlividual'~, lmcket-prirate exl>enditurl =anrl ptlblic sltending, mostly in- volving :tl eclicaid. 11 eciicare, ancl similar llrugranls. \\•ith respect to drugs, the incli- vidual is still pretty much spendin:,, his o„•u money, regardless of a;, e. In 1909, pttblic funds accounted ftir 5?`:'r of per-capita drug exlTendi- tures, comparecl with 3.3"~ in 19W Fctr people 6: aald tW\ er. tlwe lQ(P lmblic" ratio was ll.t`)"_; . . , against i.0(',e' three years earlier. For people ttnder G;. public spending accounted for only 3.1 r(' of the indiviclual's drug outlays la~,t vear, compared with 2.01 ; in lui,i, These low percentages reflect primarily the fact that Meclicitrc drtes not yet pay for out-of-husl)it;tl drug expenditures for the elderly ... while most Medicaid progrmll~, while the\ du co.•er drug.,, co~\er thenl in limited fashion. Contrasting with the drng data, the governnlent report show. th:u public funds accounted for 3' :~.t,r, of total health expenditures for thc average individual last year. Fur people over (,5, the ratio wa• 72.1 r. For thuse under (,;, it was 23' . AMERICAN DRUGGIST • Seplemlbe• 7. 19'C•

Package Power Plus... • New Formula • New Profit • And a"Peach" of a deal pARKE--DAVIS j I II I jnlPrpretuqq thr NEV,• • 21 AMERICAN DRUGGIST 0 September 7, 1970

. ve w, , .. abUild onwide ' .~. A{nfinnWit~e. on! C~ ~h/! Iar4eSt ~+it.l~ _~~3MJf"~ ~"34i ~+~++~ insure you and your employees for work- " mation +aodi fhe maA from ationwide. ~_y d ,~s h { ~ ro ,ce surance needs. One Nationwide man can :~. For complete business ins o ur .. ~ . _,..~w.,. ~~~. . . take care of virtually all your business in- =-protection is ali about. u s g businesses. like your ra ^ f Protection coverroqe'Ai `"' prt#attycioUs3rsess• thaPs w~a~~la~li~ ~= 5^, Wall O ry f110 :^ Of ~,,, R...= .....Y. ~ W~ .~,... , cializes in protection programs d , za once oryan O/1~~+ad{J ~AO~is1~ ~~ ^ s ~ natwa+e aQe-~=~Zn~~P~D~c~sx~~~~ tions in tfre i t an men's compensation, hfe, hea pen-..,,t -,, y_~ C~, -~...,,,~ >. s11'ol{ dTroQedfon. lationwide Insurance

PMA acts to improve liaison... V.B ... w,ith pharmacy by naming Ruggiero to keep in touch with profession's `grassroots' The }'ltarmacetttical \lanufac- titrers A.~,tl is illakill,'' an et'f,rrt to open new line~, (of cr,rrllnUllicatir,n with rank-ancl-file 1>harnl,tcist~ of the l*. S S. As a fir~,t step. }'\1A has ap- 1„,illte,l 1)r. I()hn Rul;;gierr, dean of I tu,llle,ne Culletc r,f f'hatrnr:tm to sen r a~, its 1.>liarnlac\ relatirm~, cc,n- <tllucnt. I)r. htl;;#;ier(i is l,resentl\ 1)n ltlc;nr. un ler,vr from "l'IC'• 9()illt; t() he c,Ur 1H)int of cr,n;ac: with nr„;.cnize,l l,harlltxcy," I1:1 Vice l,resitlt•nt I)r, l(,hn A(k;lr,!, t„]cl A m t.hic.~N I)xt cu;t<•t 1i1~, t rr tlil'~la. Grassroots: "He's also going tr- <tct rt, tru,r,it"r r,f what l,ltarmttciNtl are t:,itlkin, at the grrc>;rur,t., level. \\ e*rr nr,t alw:t~ . cr+nvincecl that the -~t,ttrmetlt~ i~snecl by the Anleri- ct:n I'ii,trnl;icelttictcl A~,sn: iatir,u ttl- tva\~, rer'lect tltt• vie\r, of the n:c- tit,n', 120,(u0H lth,,trmaci~,t,, (Cr fur that tll,,tler, e\ell the t•iew, r,f tlu ~tt,tttlt) :~}'11:1 nlenlber~. r,lll\ cite AI'llA. because they are tllr nl„>t vr,rcl tli tlle 1>hrCrltlrtcy urranizEtti„n . Iltlt, the stulle Qtl,- l,lie., tc, the \tttirmal A.snci<ttilm uf Retail 1)nll;;;ist, and other ltllar- t11acV gruttl,.,. Thrc,tl;,ll hi, visit, tr~ st tte and 1„rtl l,ll;irluacv assr,ciatinn illeetitm„,, xNe t'Ililklti H')r Ru;;pa•rco will be able tn give its an incle•- l,enclent a,sessnlent of what 1>har- maci>t~, think al,uut sunie of the comtruversial facing the ltru- fe,siuli.- Altlwnl;ll 1)r. Aclanl, clicln't nlen- ticrn it. the snb;titutiun cluesti,m- parti;nlarlx the A}'h:'1 Hnuse uf llelegate!~ altl,ruval uf a drive for repeal of the state arni-silhtititntiun laws-lrre,nnlal,ly ratlk, hif;h rrn thc• list of inlix,rtant issne". Anutller uf I)r. Kn;;I;ieru's func- tir,n, will be tr, transnlit l,llarnl:tcy's l,rc,l,lctu~, and ccnlll,laitlt, tu I"tlA in c,rcler tc, see if st,ltttic,n, can't be \N•urkecl out lrefrre these issnes get rntt of hsulcl, 1)r. Aclanls said. Frustrated: I-ur yestrti, l,harnl:tcy II~, AMERICAN DRUGGIST • Sep,embe, 7. 197C, Ila,, been fru.tratetl l,\ wh;it it cun- siclerz, to be its inal,ility tc, cliscil." inclntitr~ \vicle lrractices with clrllf; ll1a11111 act itrer.,. As 1>art of it,,, cat111,aiI;t1 to inl- Irrute relatirms with 1>hannacy. I'MA has alread\ held a clinner meetinl- between sc,nle (of its r,wrl staff nlemhers and those of the A 1-'1tA. Similar llleetin-., are schetl- ulecl with the ,tat1 ~ of the '\'A h I) and rrther l,ll,crnuccy ;:rr,ulr.'. Acc„rclin;; t() 1)r. Aclanl~,, crea- ti,m uf a new pharmacist adviso,ry co,uncil is being ,l; cnntenll,l:uc•cl by I'\1A. In anN e~ent, he saiel, an ef- fort is gr,inr tr, be rrrcrle in the nl- tllre to, s.)licit and \vei;;h l,harnl:,cN ti view 1, l,efnre I'\lA act, in ttrea., whici; will llltinltttel\ sttirct the l,rr- fe>-i. ,t; Mediation: I'\l:\ is aware that. i,ecatt.,e „f tlte cleel, rli\isi,nl., «itilil, the 1>rr,fe,siun. ul,t;tinin;; it cr,ti~erl- su, frurrl ,l,hartllac\ is not alWay• e,t<\ .} le inclicatecl that I'\1:1 is l,re- ltrecl to assttnle the rnle uf nletliat()r lu•tween theA I'll:\ an<lthc \AR I), althnitgll he warnecl that P\1A xvuulcl l,r ,ceecl cautir,utily in this rt,lc•, in urcler to, avuicl arl itnNvantecl intrnsi(m in the internal affair~, uf the r,rganizatiun.,. I)ir Aclatxt, nr,tecl that the l,lt,ir- nlacy liaisun l,u;t has existed at }'11A for 3 year6• but that it has been tmfillecl ttntil nu\c• l,ecanse uf inal,ilit\ tu find the right nl:u'. WHAT'S COMING Sept. 9-12: National Assn of Chain Drug Stores, pharmaceutical conference, Conference Center. Wil- liameburg, Va. Sept. 13-15: Pharmaceutical Wholesalers Assn. midyear meeting. San Diego. Calif. Sept. 18-21: American College of Apothecaries. annual convention, Milv,aukee. Sept. 20-23: Federal Wholesale Druggists Aasn, annual meeting, White Sulphur Springs. R. Va. Oct. 18-20: National Assn of Re- tail Druggists, annual convention. Atlantic City. Oct. 23-25: lational Catholic Pharmacists Guild. 8th annual meetin€, Holiday Inn. Baltimore. Nov. 14-19: National Q'holesale Druggists Assn, annual convention, Miami Beach. Nov. 15-18: APhA Academ} of Pharmaceutical Fcienc". 9th na- tiona] meeting. a ashingtun. D.C. Nov. 30: Pharmaceutical '`tanu. facturers Assn. midyear meeting. Vt'aldorf-Astoria,NYC. Dec. 1: N.Y. Chapter. APhA. Remington Medal dinner in honor of Dr. Don E. Francke. Hotel Roo- -evelt. NYC. Dec. 6-10: American Society of Hospital Pharmacists. midyear clin- ical meeting. Anaheim. Calif. Feb. 21-25, 1971: Toilet Guods A4sn meeting. Boca Rat„n, Fla. Mar. 6-11: Drugt:ist,' ;ernic•e Council. annual meeting and tradr show. Waldorf-Astoria, NYC:. Mar. 14-18: Pharmaceutical Wholesalers Assn. 15th annual con• vention, Dunes Hotel. Las Ve€as. Mar. 27-Apr. 2: American Phar- raae•ewtical :i~m. arnntaal mesting. San Francisco. Apr. 18-22: National A-n of Chain Drug Stores, annual meet- ing. San Juan, Puert,- Ricu. From Frye's salicylic acid to zylobalsamum Fur thuse • ncstalgic alxntt the drug business generations agu . . . and thr,se with an interest in 19th cetltury Americana, a lx,uklet jtist lntl,li,llecl rel,re,cluces a secti,nl uf the 1987 catalc,r of Meyer l,ros. & Cu., wholesale drug hurt,e of tit. 1,cnli,. Nanle t,f the vulunle is "Patent 1leclicine., and I'retl,rietary Arti- cle.,". It is available at S2.30. lrlu~- 2;r lmstawe and hanclling. frt~ul titcntyl,rr,nh :lsauciatc•s• I,us H. I'rince(,u lttnctiun, O8:~:,CI. A -lc,-l,at;e product li.,~tinw st;trt, ~+•itlt "acicl• Frye', };ranular lic", retailing at St, per clure•t, - and entl~, with z\.lulutls:tnrttnl, \lr, tl„zeu. per I r: •~, ,.. n., ~d; „• 23

FDA bans cyclamates, altogether MOTORIZER HEART CARE: Almost immedate medical care can be brought to heart attack victims with this mobile medical unit. Dr. Nanette Wenger, of Emory U, in Atlanta, left, is shown with Dr. Charles E. Harrison Jr, Atlanta Falcons team physician, and Dr. Bill Walter (driving) of the Grady Hospital Cardiology Service, gathering very early electrocardiographic and physiologic data from a heart attack patient stricken at one of Atlanta's athletic stadiums. Photo courtesy of the National Institutes of Health. APhA's Whitten asks NACDS to survey chain stores' employment practices The president of the American Pharmaceutical Assn has asked the National Assn of Chain Drug Stcrre~ to conduct a survey of its member chains "in or(ler tc, deter- mine their present eniplr,yment poli- cies and practices." The sttf;vestVnrt cante from \\'il- liam R. Whitten, who tvok office as APhA lrresi(lent last April. He is the owner of \'l'hitten Yharnla- cies. a 7-unit chain in Fort Worth, Texas, which is itself a member of NACD~;. Robert I. Iiulger, executive vice president of NACD.S, told Nlr. \'l'hitten that the idea of a survey of chain employment policies and practices "has great merit". He noted that NACDS recentl\. added to its staff "personnel to begin work to collect data on the chain drttg industry. During the next vear, we plan to condtut several surveys, including one on employment poli- cies." Complaints: ?\ir. Whitten told a nneeting of the Texas Pharm,acet1- ticaj Assn that he srigges4eil tile survey to \ ACDS because of "com- plaints received from chain phar- macv APhA members, regarding working conditions as well as the opportunity afforded salaried phar- macists to exercise professional judgment and prerugative,." I-Ie told \ACL)S that if it >wtn- dert(rok a survev. APhA would gite "full cooperation and assistance. Stuh a survey would bring to light information about the average «-ork- v,•eek, average number of hours per shift, overtime policies, non-profe~- sional supervision of pharmacy de- partments, and other working con- ditions . . . Armed with the facts. I APhA ] will be even more effective in our employee-emplover rela- tions llrograms." $2,500 to St. Louis school St. Louis College of Pharmacy has received a gift of $2500 from the Merck Company hottn(lation, on be- half of I`t erck Sharp & llohme I)i\-i- siu'n of Af ercl< & Cni. The great cyclamate 1>rr,uhah<( has drawn to a close with the dec- larati(,n by the Food &- 1)rul; A(1- nlinistrati(,n that, hencefortll, the chemical cannot be use(1 a< food ad- ditives or drng> under any circtinl- stanceti. l'ntil FI)A issued it~, latest cycltt- mate order last fortnight, it had been a' ssunlerl that marketing c,f c-,- clamate containing sweetener~ and f(luels would contintle. 1>ruvi(ling such ltr(ulucts contained a warning that they •,vere to be used onlv under the sttl,en•isirm of a Ilhysicial+. •. a rely()rt of an independent \rn% gm"ernmernt a(h-i:.,lry l;roul, un cY- cltullate~, has cnnviilce,l Fl)A that the u,,e ,Lf cyclatlattte, in any signi- ficant (lnantit\ lrre"ent, it 17nssil,le hazard t„ 1>atient.,,. The cyclanlatez, controversy fir~,t aro,;e last :,~ear when it was di;c(,v- ere(1 that rat> t,l whom high dose~ of the chemical had been a(lmini~- tere(l (levelupe(t bladder cancer~,. Followinl; last fortnil;ht'.-, an- nntmcenlent, Abbott Lall,, the na- tinn's largest llr(xltuer uf cyclanlate sweeteners, said that it htts halterl pro,(lnction and (listrihtttion r,f all >Wretetarr> cv,ntainilag, cy.c1a.n]ate~. Cyclbtntate.,, were rema',\eol frc,m lnx,st of Alrl,utt's tincarN l line sr me- tinle ago. S(llnl)1) saltl it \\'ar halt111" (ll>- tributirm of it,, artificial sweetenin, pro(hlct.,, marketed tm(lrr the S.j•eeta name, that new, non-cyclci- mate version c,f the item., are cttr- rent lc tm(ler (levelopnlent. Confusion: At the monu•nt, there is some confusion abuut the status of otttstan(linl; stocks of cyclamate containing pro(lucts. It is 1>elie\ecl, however, that pharnlacist~, an(l others will be pernlitte(1 to c(mtinue selling these until theN are e.- hauste cl. The statn, of llrescrilniun (lru;: llroclucts Nvhich involve thc tt,e ui' cyclamate cuntaininl; syrul,>, ctc., i~, als(,} il~ y1lnu1'Pt1l 24 • Infnrpre/mq the News AMERICAN DRUGGIST • Sep,embe, 7 197;